SACT Guidance, Documents and Resources

SACT Guidance, Documents and Resources

Please click on the links below to access NCCP guidance, documents and resources

Guidance Documents

NCCP Guidance on the use of Biosimilars in Cancer Treatment

NCCP Guidance on the Provision of Parenteral SACT and Supportive Care in the Community

NCCP Guidance on bevacizumab Rapid Infusion Rate

NCCP Guidance on riTUXImab Rapid Infusion Rate

NCCP Oncology Medication Safety Review

NCCP Guidance on Dose Banding for SACT

NCCP Guidance: Making Best Use of SACT Aseptic Compounding Capacity

NCCP Guidance Document for Off Site Transportation of Products from Hospital Pharmacy

NCCP Guidance: Pharmacy Benchtop preparation of monoclonal antibodies (mAbs) used in the treatment of cancer

NCCP Guidance for Medical Radioisotopes Facilities and Services in the event of Brexit

NCCP Guidance: Patient selection for the use of immunoglobulin replacement therapy in cancer patients with secondary immunodeficiency


NCCP Position Paper on the use of Tall Man Lettering

Template SOP for SACT Transportation


NCCP Olaparib Tablets Communication to Pharmacists

BRCA Testing (PARP inhibitors)

NCCP Quality Assurance Resources for Hospital Pharmacy Cancer Services

NCCP Extravasation Classification of Systemic Anti-Cancer Therapy

NCCP Capacity Planning for Parenteral SACT (Pharmacy)

NCCP Hospital Pharmacy Cancer Services Workforce Planning Framework

NCCP SACT regimens

List of approved drugs for reimbursement

NCCP Guidance on the Retention and Disposal of SACT Prescriptions and Compounding Worksheets

Education and Training

NCCP Evidence Reviews

Patient Assessment Forms

Patient Assessment Forms